$8.49 Billion is the total value of Baupost Group's 43 reported holdings in Q1 2017. The portfolio turnover from Q4 2016 to Q1 2017 was 25.0% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
LNG | CHENIERE ENERGY INC | $1,027,004,000 | +14.1% | 21,726,340 | 0.0% | 12.09% | +3.0% | |
VSAT | VIASAT INC | $839,752,000 | -3.6% | 13,158,137 | 0.0% | 9.89% | -13.0% | |
FOXA | TWENTY FIRST CENTY FOX INCcl a | $619,863,000 | +15.5% | 19,137,469 | 0.0% | 7.30% | +4.3% | |
CLNS | New | COLONY NORTHSTAR INC | $618,460,000 | – | 47,905,461 | +100.0% | 7.28% | – |
SYF | Sell | SYNCHRONY FINL | $605,910,000 | -19.2% | 17,665,000 | -14.5% | 7.13% | -27.0% |
AGN | Sell | ALLERGAN PLC | $581,198,000 | -19.4% | 2,432,603 | -29.1% | 6.84% | -27.2% |
QRVO | New | QORVO INC | $492,639,000 | – | 7,185,514 | +100.0% | 5.80% | – |
DVMT | Sell | DELL TECHNOLOGIES INC | $362,210,000 | -1.0% | 5,652,459 | -15.0% | 4.26% | -10.5% |
PBF | PBF ENERGY INCcl a | $348,605,000 | -20.5% | 15,724,175 | 0.0% | 4.10% | -28.2% | |
TBPH | THERAVANCE BIOPHARMA INC | $341,468,000 | +15.5% | 9,273,991 | 0.0% | 4.02% | +4.3% | |
AR | ANTERO RES CORP | $330,879,000 | -3.6% | 14,505,881 | 0.0% | 3.90% | -12.9% | |
QCOM | New | QUALCOMM INC | $299,085,000 | – | 5,216,000 | +100.0% | 3.52% | – |
FOX | TWENTY FIRST CENTY FOX INCcl b | $231,298,000 | +16.6% | 7,278,100 | 0.0% | 2.72% | +5.3% | |
INVA | Sell | INNOVIVA INC | $160,064,000 | +0.2% | 11,573,663 | -22.5% | 1.88% | -9.5% |
KERX | KERYX BIOPHARMACEUTICALS INC | $158,877,000 | +5.1% | 25,791,678 | 0.0% | 1.87% | -5.1% | |
VRTV | VERITIV CORP | $157,699,000 | -3.6% | 3,044,385 | 0.0% | 1.86% | -12.9% | |
MCK | MCKESSON CORP | $148,260,000 | +5.6% | 1,000,000 | 0.0% | 1.75% | -4.6% | |
FWP | Buy | FORWARD PHARMA A/Ssponsored adr | $119,927,000 | +49.0% | 5,575,407 | +3.9% | 1.41% | +34.5% |
ATRA | ATARA BIOTHERAPEUTICS INC | $110,140,000 | +44.7% | 5,359,632 | 0.0% | 1.30% | +30.7% | |
CAH | CARDINAL HEALTH INC | $83,997,000 | +13.3% | 1,030,000 | 0.0% | 0.99% | +2.4% | |
ESRX | New | EXPRESS SCRIPTS HLDG CO | $80,978,000 | – | 1,228,619 | +100.0% | 0.95% | – |
SRUNU | New | SILVER RUN ACQUISITIONunit 99/99/9999 | $69,000,000 | – | 6,615,554 | +100.0% | 0.81% | – |
LVNTA | LIBERTY INTERACTIVE CORP | $65,907,000 | +20.6% | 1,481,719 | 0.0% | 0.78% | +9.0% | |
IMOS | CHIPMOS TECHNOLOGIES INCsponsored adr | $62,300,000 | +25.8% | 3,509,858 | 0.0% | 0.73% | +13.6% | |
CACC | CREDIT ACCEP CORP MICH | $48,736,000 | -8.3% | 244,400 | 0.0% | 0.57% | -17.2% | |
BATRK | Sell | LIBERTY MEDIA CORP DELAWARE | $47,158,000 | -23.5% | 1,994,010 | -33.4% | 0.56% | -31.0% |
SYT | Sell | SYNGENTA AGsponsored adr | $46,725,000 | -20.7% | 527,968 | -29.1% | 0.55% | -28.4% |
NG | NOVAGOLD RES INC | $46,265,000 | +6.8% | 9,500,000 | 0.0% | 0.54% | -3.5% | |
GTYHU | GTY TECHNOLOGY HOLDINGS INCunit 99/99/9999 | $45,408,000 | -1.7% | 4,400,000 | 0.0% | 0.54% | -11.1% | |
ABC | AMERISOURCEBERGEN CORP | $44,469,000 | +13.2% | 502,474 | 0.0% | 0.52% | +2.3% | |
CDEV | CENTENNIAL RESOURCE DEV INCcl a | $41,663,000 | -4.4% | 2,407,153 | 0.0% | 0.49% | -13.6% | |
CPAA | CONYERS PK ACQUISITION | $39,353,000 | +3.6% | 3,712,500 | 0.0% | 0.46% | -6.5% | |
PRTK | PARATEK PHARMACEUTICALS INC | $39,357,000 | +25.0% | 2,044,498 | 0.0% | 0.46% | +12.9% | |
THERAVANCE BIOPHARMA INCnote 3.250% 11/0 | $37,763,000 | +10.9% | 30,000,000 | 0.0% | 0.44% | +0.2% | ||
CASC | Buy | CASCADIAN THERAPEUTICS INC | $36,105,000 | +101.1% | 8,721,079 | +109.3% | 0.42% | +81.6% |
AIGWS | Sell | AMERICAN INTL GROUP INC*w exp 01/19/202 | $26,905,000 | -55.8% | 1,259,012 | -51.5% | 0.32% | -60.1% |
SCAC | SABAN CAP ACQUISITION CORP | $23,242,000 | -0.1% | 2,326,500 | 0.0% | 0.27% | -9.6% | |
Sell | THERAVANCE INCnote 2.125% 1/1 | $21,398,000 | -44.2% | 22,480,000 | -51.4% | 0.25% | -49.6% | |
RUN | SUNRUN INC | $15,380,000 | +1.7% | 2,848,082 | 0.0% | 0.18% | -8.1% | |
OREXQ | OREXIGEN THERAPEUTICS INC | $7,660,000 | +97.7% | 2,226,839 | 0.0% | 0.09% | +76.5% | |
TMQ | TRILOGY METALS INC NEW | $5,797,000 | +8.6% | 10,600,758 | 0.0% | 0.07% | -2.9% | |
CPAAW | CONYERS PK ACQUISITION*w exp 07/20/202 | $2,537,000 | +2.5% | 1,237,500 | 0.0% | 0.03% | -6.2% | |
SCACW | SABAN CAP ACQUISITION CORP*w exp 09/21/202 | $1,570,000 | +42.1% | 1,163,250 | 0.0% | 0.02% | +28.6% | |
CWSA | Exit | CITIGROUP INC*w exp 01/04/201 | $0 | – | -62,903,207 | -100.0% | -0.12% | – |
LEXEA | Exit | LIBERTY EXPEDIA HOLDINGS | $0 | – | -395,613 | -100.0% | -0.20% | – |
BATRA | Exit | LIBERTY MEDIA CORP DELAWARE | $0 | – | -800,000 | -100.0% | -0.21% | – |
CLNY | Exit | COLONY CAP INCcl a | $0 | – | -6,959,017 | -100.0% | -1.84% | – |
NRF | Exit | NORTHSTAR RLTY FIN CORP | $0 | – | -14,577,134 | -100.0% | -2.88% | – |
NSAM | Exit | NORTHSTAR ASSET MGMT GROUP I | $0 | – | -18,705,000 | -100.0% | -3.64% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR/A filed 2017-05-25
About Baupost Group
Baupost Group is a Boston-based hedge fund founded by Seth Klarman in 1982. Klarman is a well-known value investor and author of the book "Margin of Safety". The firm has a reputation for being one of the most successful and secretive hedge funds in the world, with a focus on distressed debt, value investing, and event-driven strategies.
Baupost Group has a team of experienced investment professionals, including CEO and President James Mooney, COO Michael Apfel, and Chief Investment Officer Seth Klarman. The firm manages over $30 billion in assets and has a long-term investment horizon, often holding positions for several years.
The firm's investment philosophy is centered around the concept of margin of safety, which involves buying assets at a significant discount to their intrinsic value to minimize downside risk. Baupost Group is known for its disciplined approach to investing, conducting extensive research and analysis before making any investment decisions.
Baupost Group has a history of successful investments, including distressed debt investments in companies such as Enron and WorldCom. The firm also made a significant profit from its investment in the distressed debt of Lehman Brothers following the financial crisis.
Overall, Baupost Group is a highly respected hedge fund with a strong track record of successful investments. However, as with any investment, it is important for investors to conduct their own research and due diligence before making any investment decisions.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
VIASAT INC | 42 | Q3 2023 | 20.0% |
THERAVANCE BIOPHARMA INC | 38 | Q3 2023 | 4.2% |
VERITIV CORP | 37 | Q3 2023 | 10.8% |
ATARA BIOTHERAPEUTICS INC | 36 | Q3 2023 | 4.2% |
TRILOGY METALS INC NEW | 29 | Q3 2023 | 0.4% |
QORVO INC | 27 | Q3 2023 | 9.7% |
CHENIERE ENERGY INC | 25 | Q1 2020 | 19.1% |
THERAVANCE BIOPHARMA INC | 23 | Q2 2022 | 0.5% |
NOVAGOLD RES INC | 22 | Q3 2018 | 1.9% |
LIBERTY GLOBAL PLC | 21 | Q3 2023 | 16.6% |
View Baupost Group's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
Garrett Motion Inc. | August 10, 2023 | 5,987,289 | 2.3% |
Theravance Biopharma, Inc. | July 10, 2023 | 7,419,226 | 12.8% |
Outbrain Inc. | May 09, 2023 | 4,720,000 | 8.4% |
Archaea Energy Inc.Sold out | February 14, 2023 | 0 | 0.0% |
Liberty Media Corp | February 14, 2023 | 7,677,656 | 7.8% |
Altimeter Growth Corp. 2Sold out | February 13, 2023 | 0 | 0.0% |
Avanti Acquisition Corp.Sold out | February 13, 2023 | 0 | 0.0% |
Liberty Media Acquisition CorpSold out | February 13, 2023 | 0 | 0.0% |
Liberty Media Corp | February 13, 2023 | 13,651,048 | 6.2% |
VERINT SYSTEMS INCSold out | February 13, 2023 | 0 | 0.0% |
View Baupost Group's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-02-13 |
SC 13G/A | 2024-02-13 |
SC 13G/A | 2024-02-13 |
SC 13G/A | 2024-02-13 |
SC 13G | 2024-02-13 |
SC 13G | 2024-02-13 |
SC 13G/A | 2024-01-09 |
4 | 2023-12-06 |
SC 13D/A | 2023-12-04 |
13F-HR | 2023-11-13 |
View Baupost Group's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.